Skip to main content
APLM
NASDAQ Life Sciences

Selling Securityholders Register $5.6M in Class A Shares for Resale, Creating Market Overhang

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Negative
Importance info
8
Price
$20.01
Mkt Cap
$22.078M
52W Low
$3.659
52W High
$42.12
Market data snapshot near publication time

summarizeSummary

Apollomics Inc. registers 279,775 Class A Ordinary Shares for resale by selling securityholders, valued at $5.6 million, which could create market overhang.


check_boxKey Events

  • Secondary Offering Registered

    279,775 Class A Ordinary Shares, representing 13.03% of outstanding shares, are registered for resale by selling securityholders.

  • Significant Market Overhang

    The potential sale of shares valued at approximately $5.6 million, which is 25.37% of the company's market capitalization, could depress the stock price.

  • Company Receives No Proceeds

    Apollomics Inc. will not receive any cash from the sale of these shares, as it is a secondary offering by existing investors.

  • PIPE Investors Cashing Out

    The shares were acquired in a September 2025 PIPE offering at $3.9317 per share, indicating selling securityholders are realizing substantial profits.


auto_awesomeAnalysis

This F-3 filing registers 279,775 Class A Ordinary Shares for resale by selling securityholders, representing approximately 13.03% of the company's outstanding shares and a potential market value of $5.6 million. These shares originate from a private placement (PIPE) conducted on September 2, 2025, where they were acquired at $3.9317 per share. The registration enables these investors to sell their holdings at current market prices, which are significantly higher than their purchase price. While the company will not receive any proceeds from these sales, the potential influx of a substantial block of shares into the market could create an overhang and exert downward pressure on the stock price. This event allows early investors to realize significant gains, but it introduces supply-side risk for current shareholders.

At the time of this filing, APLM was trading at $20.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $22.1M. The 52-week trading range was $3.66 to $42.12. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed APLM - Latest Insights

APLM
Apr 27, 2026, 8:20 AM EDT
Filing Type: 6-K
Importance Score:
7
APLM
Apr 24, 2026, 4:24 PM EDT
Filing Type: 20-F
Importance Score:
9
APLM
Apr 08, 2026, 7:01 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
APLM
Apr 01, 2026, 4:52 PM EDT
Filing Type: 6-K
Importance Score:
9
APLM
Mar 09, 2026, 5:16 PM EDT
Filing Type: F-3
Importance Score:
8